Effects of App-assisted Home Exercise Program in Patients With Frozen Shoulder

March 31, 2025 updated by: Chih-Chi ,Chen, Chang Gung Memorial Hospital

Mobile Device Based Telerehabilitation for Frozen Shoulder-A Prospective Randomized Controlled Study.

Abstract

Introduction Frozen shoulder is a common musculoskeletal disorder with reported lifetime prevalence to be 2%~5% in the general population. Patients with frozen shoulders present with chronic pain and limited range of motion of affected shoulder and often cause an adverse impact on their daily activities and working ability. Shoulder exercises had been proven to be effective in treatment of frozen shoulders and the effects were even better after intraarticular corticosteroid injection. Strategies to enhance home exercise for patients with frozen shoulders are essential.

Objective To compare the effects of home exercises delivered by a newly developed app named Defrozen app with that by convention home exercise for frozen shoulder patients after intra-articular corticosteroid injection.

Methods and analysis This is a randomized, controlled, assessor-blinded clinical trial. Seventy-eight individuals diagnosed with frozen shoulders will be randomly divided into two groups. The primary outcome will be shoulder passive range of motion (measured with a universal goniometer). The secondary outcomes will include , shoulder pain evaluated by 11-point numeric rating scale , Oxford shoulder score and Disabilities of the arm, shoulder and hand questionnaire. Feasibility of the app includes including Technology Acceptance Model (TAM-2), System Usability Scale (SUS) and Usability, Satisfaction and Ease of Use (USE) questionnaire . The treatment will be conducted for 6 months (Defrozen app home exercise x conventional home exercise by instructions from printed pamphlets).All participants will receive outcome measurements assessment prior to randomization , 4 weeks , 12 weeks after injections interventions. Feasibility will be evaluated 4 weeks after intervention in the Defrozen app group.

Ethics and dissemination The study protocol was approved by the Institutional Review Board. The findings of the trial will be disseminated through peer-reviewed journals and scientific conferences.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The primary objective of this study is to test the hypothesis that a 12-week frozen shoulder exercise program delivered through the mobile app will result in greater improvement in shoulder range of motion compared to the control group. The control group will receive conventional home exercises provided on paper for patients with frozen shoulder after undergoing intra-articular corticosteroid injection.The secondary objective is to assess the differences in range of motion and functional outcomes between the two groups of patients. Additionally, the feasibility and acceptability of the Defrozen-App to these patients will be evaluated.

This study will employ a prospective, two-armed, assessor-blinded superiority randomized controlled trial design to compare two parallel groups of patients with primary frozen shoulder. The study was designed in accordance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines for planning interventional trials. The trial results will be reported following the Consolidated Standards of Reporting Trials (CONSORT) guidelines.

This study will be conducted in the northern branch of a medical system, which includes three hospitals located in northern Taiwan. The trial is registered [provide registration number or leave it blank if not available]. The recruitment of patients will take place in the clinic of the Department of Physical Medicine and Rehabilitation at Chang Gung Memorial Hospital, Taipei, Linko, and Taoyuan branches.

A Mobile Phone App for Demonstrating Home Exercises for Frozen Shoulder:

The Defrozen app is designed to provide simple home exercise programs for patients with frozen shoulders. It includes various features such as a training mode with exercise demonstrations, an exercise calendar, and pain evaluation.The main screen of the app displays exercise videos that are demonstrated by one of our researchers. It consists of seven sets of exercises specifically selected by physicians and a physiotherapist in our team. These exercises include Finger Walk for shoulder flexion and abduction, self-stretching exercises for shoulder external rotation and pectoral muscles, and crossover arm stretch for shoulder adduction. Additionally, towel exercises for shoulder extension and internal rotation are included. Each set of exercises consists of 10 repetitions, and we recommend performing four sessions per day. The total exercise time for one session is approximately 8 minutes. We encourage users to follow the exercise demonstrations provided in the app.After completing the exercise mode, the app prompts the patient to indicate whether they have completed the exercise and record their current pain intensity on a scale ranging from 0 to 10 . The app then transitions to the calendar mode, which displays the number of exercise sessions completed on that day and reminds the patient of the remaining sessions to be completed.

Procedures:

Participants will be recruited from the clinics of physical medicine and rehabilitation in a medical center located in northern Taiwan. Detailed information about the study will be provided to all eligible patients, and written informed consent will be obtained from each participant. All study visits will take place at a clinical laboratory near the clinics.

The assessor will collect baseline data from participants prior to randomization. Follow-up assessments will be conducted at two time points: 4 weeks after the interventions and 12 weeks after the interventions. Feasibility of the interventions will be evaluated only after the 4-week intervention period.

Random Allocation:

Random allocation of participants will be conducted using computer-generated random numbers in a 1:1 ratio. This process will be performed by one of the authors who is independent of the screening, patient recruitment, clinical care, and data collection. Subjects will be randomly assigned to either the Defrozen App group or the conventional group, ensuring equal allocation between the two groups.

The generated random number list will be placed into sequentially numbered, opaque, and sealed envelopes. These envelopes will be securely stored by the researcher responsible for allocation. Once a subject has been confirmed as eligible and has provided informed consent, the envelope corresponding to their sequential order will be opened to reveal their group allocation.

Blinding:

Participant allocation and follow-up arrangements will be overseen by a clinical researcher who will not be blinded to the participants' group assignments. However, to minimize bias, outcome measure assessments will be conducted by a physician from the study team who will be unaware of the participants' intervention groups.

Interventions In this study, all patients, regardless of their group allocation, will receive both glenohumeral joint and subacromial space injections. This decision is based on previous research that has suggested a synergistic effect of combination injections in increasing joint internal rotation angle. (Proper site of corticosteroid injection for the treatment of idiopathic frozen shoulder: Results from a randomized trial)The injections will consist of a solution containing 1 ml of 40 mg/ml triamcinolone acetonide and 1 ml of 1% lidocaine in each site. The glenohumeral joint injection will be performed blindly using an anterior approach. The needle will be inserted medially to the head of the humerus, located approximately 1 cm lateral to the coracoid process, and directed posteriorly at a slight superior and lateral angle.Previous studies have suggested that blind anterior glenohumeral joint injection yields comparable pain and functional outcomes to ultrasound-guided injection. Additionally, the anterior approach has shown better pain control and improved functional activity recovery in the early stages of primary frozen shoulder compared to the posterior approach.

For the subacromial injection, ultrasound guidance will be employed to potentially achieve greater clinical improvement in shoulder pain compared to blind injection.Following the injections, patients will receive instructions on performing the seven sets of frozen shoulder exercises mentioned earlier. The APP group will be guided through the exercises using the mobile app, while the conventional group will be provided with a printed pamphlet illustrating the exercises. Each set of exercises will involve 10 repetitions, and it is recommended to perform four sessions per day. Additionally, all patients will be prescribed two weeks of nonsteroidal anti-inflammatory drugs (aceclofenac) to manage pain and inflammation.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taoyuan, Taiwan
        • Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Eligibility Criteria:

Patients with frozen shoulder who are scheduled to receive intra-articular glucocorticosteroid injections, as determined by the physician investigator, will be consecutively enrolled in the study. To be included in the study, patients must meet the following criteria:

  1. Unilateral frozen shoulder.
  2. Suitability for treatment with intra-articular and subacromial glucocorticosteroid injection.
  3. Patients must fulfill the diagnostic criteria for frozen shoulder, as described by Bulgen et al. These criteria include shoulder pain persisting for at least 1 month, sleep disturbance (such as night pain or inability to lie on the affected side), restriction of all active and passive shoulder movements, and a reduction of passive glenohumeral external rotation by at least 50% compared to the unaffected side.
  4. Plain radiographs of the shoulder will be obtained to exclude other pathologies.

Patients will be excluded from the study if they meet any of the following criteria:

  1. Age younger than 20 years old.
  2. Bilateral involvement of the shoulder.
  3. Secondary frozen shoulder resulting from trauma.

  4. History of shoulder joint injections or upper limb surgery within the past month.

    Presence of rheumatoid arthritis, central nervous system disorders, or cervical radiculopathy.

  5. Cognitive disorders or inability to understand exercise instructions.
  6. Contraindications for anesthesia or corticosteroid injection.
  7. Lack of familiarity with using smartphones.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: App intervention group
Patients will receive instructions on performing the seven sets of frozen shoulder exercises mentioned earlier. The APP intervention group will be guided through the exercises using the mobile app. Each set of exercises will involve 10 repetitions, and it is recommended to perform four sessions per day.
Drug: Glenohumeral joint and subacromial space triamcinolone injections

All patients will receive both glenohumeral joint and subacromial space injections. The injections will consist of a solution containing 1 ml of 40 mg/ml triamcinolone acetonide and 1 ml of 1% lidocaine in each site. The glenohumeral joint injection will be performed blindly using an anterior approach. The needle will be inserted medially to the head of the humerus, located approximately 1 cm lateral to the coracoid process, and directed posteriorly at a slight superior and lateral angle.

Patients will be educated on how to perform the 7 sets of frozen shoulder exercise. Subjects will be advised to perform all the exercises to a point that they may feel tightness but not painful and hold to the point for 2-3 seconds.

Device: App-assisted exercise
Patients will be educated on how to perform the 7 sets of frozen shoulder exercise. Subjects will be advised to perform all the exercises to a point that they may feel tightness but not painful and hold to the point for 2-3 seconds. Then the APP group will suggest performing the exercise from APP education The APP intervention group will be guided through the exercises using the mobile app, while the conventional group will be provided with a printed pamphlet illustrating the exercises.. Each set exercise will have 10 repetitions and investigators recommend 4 sessions per day.
Drug: Nonsteroidal anti-inflammatory drugs (aceclofenac)
All patients will be prescribed two weeks of nonsteroidal anti-inflammatory drugs (aceclofenac) .
Active Comparator: Conventional group
patients will receive instructions on performing the seven sets of frozen shoulder exercises mentioned earlier. The conventional group will be provided with a printed pamphlet illustrating the exercises. Each set of exercises will involve 10 repetitions, and it is recommended to perform four sessions per day.
Drug: Glenohumeral joint and subacromial space triamcinolone injections

All patients will receive both glenohumeral joint and subacromial space injections. The injections will consist of a solution containing 1 ml of 40 mg/ml triamcinolone acetonide and 1 ml of 1% lidocaine in each site. The glenohumeral joint injection will be performed blindly using an anterior approach. The needle will be inserted medially to the head of the humerus, located approximately 1 cm lateral to the coracoid process, and directed posteriorly at a slight superior and lateral angle.

Patients will be educated on how to perform the 7 sets of frozen shoulder exercise. Subjects will be advised to perform all the exercises to a point that they may feel tightness but not painful and hold to the point for 2-3 seconds.

Drug: Nonsteroidal anti-inflammatory drugs (aceclofenac)
All patients will be prescribed two weeks of nonsteroidal anti-inflammatory drugs (aceclofenac) .

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change shoulder active range of motion in degree
Time Frame: prior to randomization, 4-weeks after interventions and 12-weeks after intervention
The range of motion of the shoulder will be assessed using a universal goniometer, which measures the angle of movement between specific bone landmarks. The investigator will evaluate the active range of motion of the affected shoulder, including flexion, abduction, internal rotation, and external rotation, using the goniometer to determine the degrees of movement in each direction. Active range of movement of the affected shoulder, including flexion, abduction, internal rotation, and external rotation, will be measured by goniometer in degree.
prior to randomization, 4-weeks after interventions and 12-weeks after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Shoulder pain by Numeric Rating Scale (NRS)
Time Frame: prior to randomization, 4-weeks after interventions and 12-weeks after intervention
To assess shoulder pain, investigators will utilize an 11-point NRS. Patients will be informed that a score of 0 represents no pain, while a score of 10 indicates the highest level of pain.
prior to randomization, 4-weeks after interventions and 12-weeks after intervention
Change of Oxford shoulder score (OSS).
Time Frame: prior to randomization, 4-weeks after interventions and 12-weeks after intervention
A patient-rated outcome measure of shoulder pain and function in patients with shoulder pain. OSS has twelve questions with five possible responses ranging from 0 (worst) to 4 (best).
prior to randomization, 4-weeks after interventions and 12-weeks after intervention
Change of Quick Disability of the Arm, Shoulder and Head (QuickDASH) score
Time Frame: prior to randomization, 4-weeks after interventions and 12-weeks after intervention
The QuickDASH is a modified version of the original 30-item Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire, consisting of 11 items. A minimum of 10 items must be completed by the participant. Each item has five response options.The total QuickDASH score ranges from 0 (indicating no disability) to 100 (representing the most severe disability)
prior to randomization, 4-weeks after interventions and 12-weeks after intervention
Selected part of revised Technology Acceptance Model (TAM-2)
Time Frame: 4 weeks after intervention in App intervention group
The selected part of revised Technology Acceptance Model(TAM-2) including intention to use, perceived usefulness and perceived ease of use. Participants will be asked to rate their agreement with each statement on a five-point Likert scale, ranging from "Strongly Disagree" to "Strongly Agree."
4 weeks after intervention in App intervention group
System Usability Scale (SUS)
Time Frame: 4 weeks after intervention in App intervention group
he SUS is a standardized questionnaire that consists of ten statements related to the usability of the application. Participants will be asked to rate their agreement with each statement on a five-point Likert scale, ranging from "Strongly Disagree" to "Strongly Agree."
4 weeks after intervention in App intervention group
Usability, Satisfaction and Ease of Use (USE) questionnaire
Time Frame: 4 weeks after intervention in App intervention group
The questionnaire consists of four statements related to the system or application being evaluated. Participants will be asked to rate their agreement with each statement on a five-point Likert scale, ranging from "Strongly Disagree" to "Strongly Agree."
4 weeks after intervention in App intervention group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chang Gung Memorial Hospital

Investigators

  • Principal Investigator: Chih-Chi Chen, Chang Gung Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 11, 2022

Primary Completion (Actual)

October 20, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

November 21, 2022

First Submitted That Met QC Criteria

July 31, 2023

First Posted (Actual)

August 8, 2023

Study Record Updates

Last Update Posted (Actual)

April 3, 2025

Last Update Submitted That Met QC Criteria

March 31, 2025

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Defrozen_Shoulder_App

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe